Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-24 @ 11:58 PM
NCT ID:
NCT00263458
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18 years
* Fluent in English
* Receive HIV primary care at the UCSF Positive Health Program
* Meet DSM-IVR criteria for opioid dependence
* Meet clinical criteria for buprenorphine treatment (see Exclusion Criteria)
* Plan to stay in the San Francisco Bay Area for the next 12 months
Exclusion Criteria:
* Severe hepatic dysfunction, i.e., AST and/or ALT \> 5X upper limit of normal
* DSM-IV criteria for benzodiazepine abuse or dependence within the past 6 months
* DSM-IV criteria for alcohol dependence within the past 6 months
* Actively suicidal
* Psychiatric impairment that impedes ability to consent (dementia, delusional, actively psychotic)
* Methadone or opiate analgesic doses exceed level allowing for safe transition to buprenorphine
* Pregnant women and women actively trying to become pregnant
Potential subjects also will be excluded for:
* Any medical condition(s), which, in the opinion of the investigator, would interfere with the patient's ability to participate in or adhere to the requirements of this study
* Unable or who decline to provide informed consent for the evaluation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT00263458
Study Brief:
Protocol Section:
NCT00263458